NF-κB, stem cells and breast cancer: the links get stronger.
about
Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancerSustained proliferation in cancer: Mechanisms and novel therapeutic targetsSNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenanceExome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers.NF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells.NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth.Transglutaminase regulation of cell function.Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer.Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways.Recombinant fibromodulin and decorin effects on NF-κB and TGFβ1 in the 4T1 breast cancer cell line.Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerCell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity.Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.A Novel Unsupervised Algorithm for Biological Process-based Analysis on Cancer.IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice.Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.Modeling the estrogen receptor to growth factor receptor signaling switch in human breast cancer cellsBmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling.Constitutive activation of STAT3 signaling regulates hTERT and promotes stem cell-like traits in human breast cancer cells.Trianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways.Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells.Circadian disruption-induced microRNAome deregulation in rat mammary gland tissues.Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer.Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem Cells.Expression of NF-κB-inducing kinase in breast carcinoma tissue and its clinical significance.Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cellsExposure to ionizing radiation induced persistent gene expression changes in mouse mammary glandGalNAc-T14 promotes metastasis through Wnt dependent HOXB9 expression in lung adenocarcinomaDisulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.Dynamic changes in the gene expression profile during rat oral carcinogenesis induced by 4-nitroquinoline 1-oxideThe oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma.Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal.Next-generation proteasome inhibitor MLN9708 sensitizes breast cancer cells to doxorubicin-induced apoptosis
P2860
Q26824316-3D5451A1-04F8-4BBE-9EF0-06722AC429C7Q28396388-6131001B-BF4E-4BAD-A196-1DA26CA2DE51Q28533971-CED1B0BF-736A-4332-BC88-759BDB2B3469Q30372977-ACD13FF8-6F9F-4F65-9B3D-C2CCA7E0F6E6Q30417710-00F81EBF-B436-4473-8AC8-3D5E8D830EBCQ33632205-EE1AAC77-76E4-4904-9504-7357A60C8E2DQ33707936-7E780B31-4D3C-46C7-9631-A34721D740C5Q33745632-25A82F0D-E429-4232-B6FB-B26D4FC826F3Q33749203-DCEEBB42-111E-45CB-BFED-900A8EB80276Q33750977-C5FE584A-AE43-48CD-A86A-C785EC40D21AQ33757061-A3BA8B05-3BFF-4452-A6B4-99EE7BAB5ABCQ33760216-013C955D-AD4F-42E2-ACCA-3526EA9F01BDQ33767473-807C5D62-6FF7-4392-AAE4-211BF2141E31Q33814357-16453324-4CFE-4EB4-9DC1-C5EC8A409607Q33875947-837A30E8-1D38-4DC5-831C-39FE6368432EQ33913799-9954B533-DF6F-4942-AC55-FA47BBBE9DD7Q33949184-82CFB485-E65B-416B-8A5F-FAFFBB8DD01AQ34039445-BA480E7F-96F1-4D67-8469-080AA4127A3AQ34103963-266280F0-514C-4BF9-AE1E-561DA5F4B664Q34346672-4FC680E1-5DE1-43D0-8AD1-EE456D1F2BFDQ34367908-D8095BFA-D084-42D8-AD3E-0E546B7FC5C5Q34469657-935FA836-B875-4D31-B917-C500FBF8F966Q34916123-6E57D3A3-42C3-4104-AB00-C2C4248B27BBQ35080781-0C33EBBC-91A6-4560-8995-4215C59266F5Q35138880-CF500742-4381-4982-9F81-46246D97C457Q35181463-62679901-ECC3-4419-B9CD-AED711AFA7C6Q35671776-A56C3BB6-2260-49D4-AF4A-34BE5A13032FQ35745008-B5AAF365-EA9C-4199-BF0C-798CCC71D5C7Q35977804-CC61BE85-E647-49A3-9560-6A3042217CD1Q36016253-C37A020E-6220-4964-93E1-503AEF858C71Q36237226-3CD29CD7-47C7-47BD-ADAA-98F386D1335DQ36464655-B8FF2BD3-4335-4D87-8E08-D914A90A5F29Q36485168-5D5BD53D-5C67-4333-AB37-40DA623C7400Q36552489-0CB4E964-374B-4663-8837-278B219EDDD6Q36561625-A6C6C38D-94B1-47E5-AFE2-A8CC5B402CA6Q36562209-0C40B6F6-A1F2-4937-AC2C-E65F63591EECQ36624005-C2BCB360-700A-41DB-968B-6825BA00DD72Q36738884-2EE67D8D-0C81-481A-AF5B-DFB36858F9BCQ36898047-DB81F022-3641-4B0C-94F1-D99B183DDD1EQ36928677-8A42527B-5E46-4550-82E3-AA0CB1DCAA90
P2860
NF-κB, stem cells and breast cancer: the links get stronger.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
NF-κB, stem cells and breast cancer: the links get stronger.
@ast
NF-κB, stem cells and breast cancer: the links get stronger.
@en
type
label
NF-κB, stem cells and breast cancer: the links get stronger.
@ast
NF-κB, stem cells and breast cancer: the links get stronger.
@en
prefLabel
NF-κB, stem cells and breast cancer: the links get stronger.
@ast
NF-κB, stem cells and breast cancer: the links get stronger.
@en
P2860
P921
P356
P1476
NF-κB, stem cells and breast cancer: the links get stronger.
@en
P2093
Alain Chariot
Kateryna Shostak
P2860
P2888
P356
10.1186/BCR2886
P577
2011-07-26T00:00:00Z
P5875
P6179
1017415193